Skip to main content
. 2021 Feb 25;13:589296. doi: 10.3389/fnagi.2021.589296

Table 3.

Number (%) of subjects or median (IQR) for each of the baseline variables by age grouping.

All 18–34 35–44 45–54 55–64 65–93 P-value
(n = 543) (n = 81) (n = 80) (n = 94) (n = 120) (n = 168)
Female 304 (56.0) 53 (65.4) 50 (62.5) 59 (62.8) 54 (45.0) 88 (52.4) 0.012
Right hand side implant 313 (57.6) 59 (72.8) 52 (65.0) 54 (57.4) 54 (45.0) 94 (56.0) 0.002
Additional handicap 42 (7.8) 5 (6.2) 6 (7.6) 3 (3.2) 11 (9.2) 17 (10.3) 0.302
HL degree (implant ear) 0.163
  Mild-moderately severe 26 (5.0) 2 (2.5) 2 (2.7) 2 (2.3) 8 (6.8) 12 (7.5)
  Severe 117 (22.5) 18 (22.5) 11 (14.7) 19 (22.1) 26 (22.2) 43 (27.0)
  Profound 374 (72.3) 60 (75.0) 62 (82.7) 65 (75.6) 83 (70.9) 104 (65.4)
HL degree (non-implant ear) 0.032*
  Normal 28 (5.5) 4 (5.1) 4 (5.4) 8 (9.3) 8 (6.9) 4 (2.6)
  Mild-moderately severe 82 (16.1) 7 (9.0) 7 (9.5) 12 (14.0) 22 (19.0) 34 (21.8)
  Severe 133 (26.1) 22 (28.2) 14 (18.9) 29 (33.7) 27 (23.3) 41 (26.3)
  Profound 267 (52.4) 45 (57.7) 49 (66.2) 37 (43.0) 59 (50.9) 77 (49.4)
Presence of tinnitus 283 (53.2) 33 (42.9) 46 (59.0) 58 (62.4) 62 (51.7) 84 (51.2) 0.127
Presence of dizziness 238 (44.7) 27 (35.1) 29 (37.2) 48 (51.6) 55 (45.8) 79 (48.2) 0.119
Hearing aid (implant ear) 329 (60.6) 49 (60.5) 50 (62.5) 53 (56.4) 71 (59.2) 106 (63.1) 0.851
Hearing aid (non-implant ear) 338 (62.2) 46 (56.8) 45 (56.2) 65 (69.1) 72 (60.0) 110 (65.5) 0.271
Telephone use 281 (52.8) 43 (55.8) 39 (50.0) 55 (59.1) 68 (56.7) 76 (46.3) 0.240
Median duration of HL (years) 21 (25) 21 (15) 28 (31) 20 (26) 17 (34.5) 20 (19) 0.661

P-values are from chi-squared tests for categorical variables and analysis of variance for continuous variables; HL, hearing loss; IQR, interquartile range; *Fisher’s exact test used because of small counts.